Skip to main content
. 2018 Aug 31;70(6):822–827. doi: 10.1016/j.ihj.2018.08.019

Fig. 1.

Fig. 1

Distribution of NT-proBNP values in patients with and without elevated sST2 levels at baseline. NT-proBNP, N-terminal probrain natriuretic peptide; sST2, soluble suppression of tumorigenicity-2.